After Katie Couric was diagnosed with breast cancer this summer, one of the first questions swirling in her head was whether she would need a mastectomy — or surgery to remove the entire breast. But ...

Each year more than 200,000 women diagnosed with early-stage breast cancer, the most common kind, must make myriad treatment decisions. Among them: whether to have a mastectomy or breast-conserving ...

Many patients undergoing lumpectomy surgery at NYU Langone Medical Center for the removal of an early detected breast tumor - the surgical option of choice for this diagnosis -- are benefitting from ...

Many women who are diagnosed with breast cancer face the difficult decision of whether to have a lumpectomy with radiation or a mastectomy with reconstruction. With the availability of study results ...

In a clinical trial of 406 patients, Mass General Cancer Center investigators found that real-time imaging using a fluorescent agent had a favorable impact for 1 in 10 patients, with potential to ...

Dr. Silverstein answers: 'What If More Cancer is Found During Lumpectomy?' — -- Question: What will the surgeon do if more cancer is evident during lumpectomy surgery? Answer: If more cancer is ...

It is well established that breast conservation, which involves the removal of a breast cancer along with a small rim of normal breast tissue around it and is followed by radiation therapy, is at ...

The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is ...